Literature DB >> 21390475

Managing scleromyxedema with intravenous immunoglobulin: acute worsening of scleromyxedema with biclonal gammopathy.

I Manousaridis1, C Loeser, S Goerdt, J C Hassel.   

Abstract

Scleromyxedema is a rare chronic cutaneous mucinosis usually associated with a monoclonal gammopathy and underlying systemic disease. The etiology of the disease is not known. There are no standard treatments and response to various therapeutic modalities varies. We report a case of refractory scleromyxedema in a 63-year-old man with a biclonal IgG and IgM λ-gammopathy. The patient was successfully managed with intravenous immunoglobulin.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21390475

Source DB:  PubMed          Journal:  Acta Dermatovenerol Alp Pannonica Adriat        ISSN： 1318-4458


  9 in total

1.  [Scleromyxedema. A chronic progressive systemic disease].

Authors:  A Kreuter; M Stücker; A G A Kolios; P Altmeyer; K Möllenhoff
Journal:  Z Rheumatol       Date:  2012-08       Impact factor: 1.372

2.  Scleromyxedema: An Atypical Case.

Authors:  Emy Thomas; Anisha George; Divya Deodhar; Mary John
Journal:  Indian J Dermatol       Date:  2015 May-Jun       Impact factor: 1.494

3.  Unusual type of scleromyxedema with multiple subcutaneous nodules, IgM-λ paraproteinemia, and scleroderma-like microangiopathy.

Authors:  Kentaro Awaji; Yoshihide Asano; Mariko Takaoka; Tomonori Oka; Tomomi Miyake; Hiraku Suga; Shinichi Sato
Journal:  J Scleroderma Relat Disord       Date:  2020-12-01

4.  [Differential diagnose of angioedema. Acute edematous scleromyxedema].

Authors:  S Gerstner; H Kneitz; E-B Bröcker; A Trautmann
Journal:  Hautarzt       Date:  2014-05       Impact factor: 0.751

Review 5.  Lichen myxedematosus: a rare group of cutaneous mucinosis.

Authors:  Ramiro Eugenio Cárdenas-Gonzalez; Maira Elizabeth Herz Ruelas; Jorge Ocampo Candiani
Journal:  An Bras Dermatol       Date:  2019-10-17       Impact factor: 1.896

6.  An unusual case of granulomatous scleromyxedema.

Authors:  Lauren Michelle; Sara Sabeti; Katerina Yale; Brittany Urso; Bonnie Lee; Janellen Smith
Journal:  JAAD Case Rep       Date:  2022-07-02

7.  Scleromyxedema with subcutaneous nodules: successful treatment with thalidomide and intravenous immunoglobulin.

Authors:  M Dolenc-Voljč; V Jurčić; A Hočevar; M Tomšič
Journal:  Case Rep Dermatol       Date:  2013-11-02

8.  Scleromyxedema: a rare disorder and its treatment difficulties.

Authors:  Sandra Koleta Koronowska; Agnieszka Osmola-Mańkowska; Oliwia Jakubowicz; Ryszard Zaba
Journal:  Postepy Dermatol Alergol       Date:  2013-04-12       Impact factor: 1.837

9.  Long-term efficacy of high doses of intravenous immunoglobulins in generalized scleromyxoedema: Case report.

Authors:  Federica Arginelli; Franco Rongioletti; Giampiero Girolomoni; Giovanni Pellacani; Davide Guardoli; Andrea Conti
Journal:  J Int Med Res       Date:  2016-09       Impact factor: 1.671
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.